BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 15953588)

  • 1. Angiogenesis inhibitors: from laboratory to clinical application.
    Nakamura T; Matsumoto K
    Biochem Biophys Res Commun; 2005 Jul; 333(2):289-91. PubMed ID: 15953588
    [No Abstract]   [Full Text] [Related]  

  • 2. Angiogenesis--a new target for future therapy.
    Pandya NM; Dhalla NS; Santani DD
    Vascul Pharmacol; 2006 May; 44(5):265-74. PubMed ID: 16545987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Targeting angiogenesis in oncology].
    Fayette J; Soria JC; Armand JP
    Pathol Biol (Paris); 2006 May; 54(4):199-205. PubMed ID: 16753494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenesis and current antiangiogenic strategies for the treatment of cancer.
    Oklu R; Walker TG; Wicky S; Hesketh R
    J Vasc Interv Radiol; 2010 Dec; 21(12):1791-805; quiz 1806. PubMed ID: 20980167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenesis: a "common denominator" of disease?
    Piascik P
    J Am Pharm Assoc (Wash); 2000; 40(4):564-5. PubMed ID: 10932469
    [No Abstract]   [Full Text] [Related]  

  • 6. Current insights on the biology and clinical aspects of VEGF regulation.
    Birk DM; Barbato J; Mureebe L; Chaer RA
    Vasc Endovascular Surg; 2008 Dec-2009 Jan; 42(6):517-30. PubMed ID: 18799497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor.
    Ferrara N
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):789-91. PubMed ID: 19164810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies.
    Shojaei F; Ferrara N
    Drug Resist Updat; 2008 Dec; 11(6):219-30. PubMed ID: 18948057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Embellistatin, a microtubule polymerization inhibitor, inhibits angiogenesis both in vitro and in vivo.
    Jung HJ; Shim JS; Lee HB; Kim CJ; Kuwano T; Ono M; Kwon HJ
    Biochem Biophys Res Commun; 2007 Feb; 353(2):376-80. PubMed ID: 17184734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenesis: an organizing principle for drug discovery?
    Folkman J
    Nat Rev Drug Discov; 2007 Apr; 6(4):273-86. PubMed ID: 17396134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose anthracyclines may block HIF-1 and stop tumor growth.
    Hede K
    J Natl Cancer Inst; 2009 Mar; 101(6):368-70. PubMed ID: 19276456
    [No Abstract]   [Full Text] [Related]  

  • 12. [VEGF, anti-vEGF and diseases].
    Corvol P
    Bull Acad Natl Med; 2008 Feb; 192(2):289-300; discussion 300-2. PubMed ID: 18819684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody against junctional adhesion molecule-C inhibits angiogenesis and tumor growth.
    Lamagna C; Hodivala-Dilke KM; Imhof BA; Aurrand-Lions M
    Cancer Res; 2005 Jul; 65(13):5703-10. PubMed ID: 15994945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metronomic chemotherapy: teaching old drugs new tricks?
    Vogelzang N
    Clin Adv Hematol Oncol; 2004 Jul; 2(7):432-3. PubMed ID: 16163217
    [No Abstract]   [Full Text] [Related]  

  • 15. Angiogenesis as a therapeutic target.
    Ferrara N; Kerbel RS
    Nature; 2005 Dec; 438(7070):967-74. PubMed ID: 16355214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiangiogenic therapy for cancer: an update.
    Shojaei F; Ferrara N
    Cancer J; 2007; 13(6):345-8. PubMed ID: 18032969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.
    Pradeep CR; Sunila ES; Kuttan G
    Integr Cancer Ther; 2005 Dec; 4(4):315-21. PubMed ID: 16282508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tumor-associated macrophages in the prospect of development of targeted cancer therapy].
    Skivka LM; Horbyk HV; Fedorchuk OH; Pozur VV
    Tsitol Genet; 2009; 43(4):71-82. PubMed ID: 19938649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different ways to antiangiogenesis by angiostatin and suramin, and quantitation of angiostatin-induced antiangiogenesis.
    Bahramsoltani M; Plendl J
    APMIS; 2007 Jan; 115(1):30-46. PubMed ID: 17223849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On metronomic chemotherapy: modulation of angiogenesis mediated by VEGE-A.
    Albertsson P; Lennernäs B; Norrby K
    Acta Oncol; 2006; 45(2):144-55. PubMed ID: 16546859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.